News & SEC Filings
News
14 May 2020Company News, Regulatory
Verona Pharma Announces FDA Response to End-of-Phase 2 Briefing Package for Ensifentrine in COPD and Outlines Phase 3 ENHANCE Clinical Program
LONDON, May 14, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it has received written comments from the U.S. Food and Drug Administration (FDA) in response to its End-of-Phase 2 briefing package for nebulized ensifentrine as a maintenance treatment for chronic obstructive pulmonary disease (“COPD”).
12 May 2020Regulatory
Director/PDMR Shareholding - Grant of Restricted Stock Units, Issue of Equity, Total Voting Rights & PDMR Dealings
LONDON, May 12, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces that it has on May 7, 2020 granted to
1 May 2020Regulatory
Verona Pharma Presents Expanded Analysis of Ensifentrine Clinical Data in COPD Maintenance Treatment at the American Thoracic Society 2020 International Conference
Analysis supports ensifentrine’s efficacy in COPD as monotherapy and on top of standard of care treatment in patients who remain symptomatic Six abstracts accepted demonstrating ensifentrine’s potential across treatment settings and formulations LONDON, May 01, 2020 (GLOBE NEWSWIRE) -- Verona
30 April 2020Regulatory
Verona Pharma plc: Operational Update and Financial Results for the Three Months Ended March 31, 2020
Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces financial results for the three months ended March 31, 2020, and provides a corporate update. Conference call today at 9:00 am EDT / 2:00 pm BST.
23 April 2020Regulatory
Verona Pharma to Announce Financial Results for the Three Months Ended March 31, 2020 and Provide Corporate Update
LONDON, April 23, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will report its financial results for the three months ended March 31, 2020 on Thursday, April 30, 2020 and host an investment community conference call at 9:00 a.m. EDT / 2:00 p.m. BST to discuss the financial results and provide a corporate update.
SEC Filings
| Date | Description | Form | Filing Group | View |
|---|---|---|---|---|
| 14 May 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 30 Apr 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 30 Apr 2020 | Securities offered to employees pursuant to employee benefit plans | S-8 | Registration Statements | |
| 16 Apr 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 14 Apr 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 06 Apr 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 30 Mar 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 10 Mar 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 27 Feb 2020 | Registration of securities of foreign private issuers pursuant to section 12(b) or (g) | 20-F | Annual Filings | |
| 05 Feb 2020 | An amendment to the SC 13G filing | SC 13G/A | Other | |
| 04 Feb 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 17 Jan 2020 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 29 Nov 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 22 Nov 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 22 Nov 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 05 Nov 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 19 Sep 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 14 Aug 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 08 Aug 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 07 Aug 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 05 Jun 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 14 May 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 07 May 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 03 May 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 12 Apr 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 02 Apr 2019 | Filing by person(s) reporting owned shares of common stock in a public company >5% | SC 13D | Other | |
| 26 Mar 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 26 Mar 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 19 Mar 2019 | Registration of securities of foreign private issuers pursuant to section 12(b) or (g) | 20-F | Annual Filings | |
| 12 Mar 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 28 Feb 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 12 Feb 2019 | An amendment to the SC 13G filing | SC 13G/A | Other | |
| 11 Feb 2019 | An amendment to the SC 13G filing | SC 13G/A | Other | |
| 04 Jan 2019 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 06 Nov 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 25 Sep 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 14 Aug 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 07 Aug 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 28 Jun 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 04 Jun 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 01 Jun 2018 | EFFECT | EFFECT | Other | |
| 22 May 2018 | Registration statement for certain foreign private issuers offered for certain transactions | F-3 | Registration Statements | |
| 08 May 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 04 May 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 04 May 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 18 Apr 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 29 Mar 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 22 Mar 2018 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 27 Feb 2018 | Annual Report of foreign issuer rules 13 and 15(d) of the Securities Exchange Act | 20-F | Annual Filings | |
| 13 Feb 2018 | An amendment to the SC 13G filing | SC 13G/A | Other | |
| 06 Feb 2018 | An amendment to the SC 13G filing | SC 13G/A | Other | |
| 26 Jan 2018 | An amendment to a SC 13D filing | SC 13D/A | Other | |
| 09 Nov 2017 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 21 Sep 2017 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 12 Sep 2017 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 24 Aug 2017 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 08 Aug 2017 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 26 May 2017 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 18 May 2017 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 12 May 2017 | A statement of beneficial ownership of common stock by certain persons | SC 13G | Other | |
| 09 May 2017 | Filing by person(s) reporting owned shares of common stock in a public company >5% | SC 13D | Other | |
| 09 May 2017 | A statement of beneficial ownership of common stock by certain persons | SC 13G | Other | |
| 08 May 2017 | A statement of beneficial ownership of common stock by certain persons | SC 13G | Other | |
| 08 May 2017 | Filing by person(s) reporting owned shares of common stock in a public company >5% | SC 13D | Other | |
| 08 May 2017 | Filing by person(s) reporting owned shares of common stock in a public company >5% | SC 13D | Other | |
| 05 May 2017 | A statement of beneficial ownership of common stock by certain persons | SC 13G | Other | |
| 05 May 2017 | A statement of beneficial ownership of common stock by certain persons | SC 13G | Other | |
| 03 May 2017 | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 6-K | Current Reports | |
| 01 May 2017 | CT ORDER | CT ORDER | Other | |
| 28 Apr 2017 | Securities offered to employees pursuant to employee benefit plans | S-8 | Registration Statements | |
| 28 Apr 2017 | Form of prospectus disclosing information facts events covered in both forms 424B1 424B3 | 424B4 | Registration Statements | |
| 26 Apr 2017 | This filing is a pre-effective amendment to an F-1 filing | F-1/A | Registration Statements | |
| 26 Apr 2017 | Registration of up to an additional 20% of securities for an offering filed on an F-1 | F-1MEF | Registration Statements | |
| 26 Apr 2017 | EFFECT | EFFECT | Other | |
| 26 Apr 2017 | EFFECT | EFFECT | Other | |
| 21 Apr 2017 | CERTNAS | CERTNAS | Other | |
| 19 Apr 2017 | CERTNAS | CERTNAS | Other | |
| 19 Apr 2017 | Registration of certain classes of securities 12(b) of the Securities Exchange Act | 8-A12B | Registration Statements | |
| 18 Apr 2017 | This filing is a pre-effective amendment to an F-1 filing | F-1/A | Registration Statements | |
| 18 Apr 2017 | Registration of depository shares evidenced by American Depository Receipts | F-6 | Registration Statements | |
| 03 Apr 2017 | Registration statement for certain foreign private issuers | F-1 | Registration Statements | |
| 13 Feb 2017 | A statement of beneficial ownership of common stock by certain persons | SC 13G | Other | |
| 20 Jul 2016 | - | D | Other |
Verona Pharma
Investor Information
© Verona Pharma plc 2020. All rights reserved